Logo
Data Snapshot
Login Register
COVID-19-Briefing-note-40-January-27-2021-vF.pdf?shouldIndex=f
auto-generated 31-Jan-2021
Risk Practice COVID-19 and the great reset: Briefing note #40, January 27, 2021 Vaccine rollout has run into problems. Our new research explores where and why. January 2021 Eugene Mymrin/Getty Images McKinsey research intently continues to examine the progress of SARS-CoV-2 vaccine development and distribution. Last week, we updated our series on the end of the pandemic to consider the emergence of new strains of the virus and a slow start to vaccine rollout. Both represent serious threats to th

Keywords

critical risk areas risk practice critical risk vaccine risk areas emergent threat risk critical operating path

Sources: McKinsey

Pathway Demo and Download Data

You can download the excel file containing Categories, Goals, Measures and Actions. Please use Lunge App, to try the pathway data.
Download Pathway Data
This section lists the Pathway type, Priority/ function areas, Sectors/ fields of life and People/ roles for the pathway.
Type:   Strategies
Priority/ Function Areas:   Business & Industrial  Computers & Electronics  Finance  Internet & Telecom
Sectors/ Fields of Life:   Manufacturing  Wholesale & Retail Trade  Information, Finance & Insurance  Technical & Management Services
People/ Roles:   Consumer Services  Service Vendors  Manufacturers  Multi-Nationals  Governments
This section lists the Categories, Goals, Measures and Actions included in the pathway.
Categories:   exhibit   look   research   global   threat   report   machine   state   normal   natural   point   covid-19   consider   challenge   record   digital   system   briefing   material   operations   risk   emission   world   collection   country   great   solution   operate   management   relate   area   event   adverse   critical   patient   climate   vaccine   administration   coronavirus   greatly   mckinsey   january   reset
Profiles:   all rights   the shifts   the pandemic   a map   mckinsey perspectives   we editors   the recovery   the case   mckinsey exhibit   we collection   iz events   the emergence   a report   the installment   the value
Goals:   scale risk areas   vulnerability new research   bolster basic system   rebuild climate challenge   consider urgent need   manufacture materials fill   forecast inventory management   prioritization analysis literature   see full collection   need emergent logistics   challenge communications provider   mitigate damaging effects   need scheduling onboarding   prioritization vaccine system   map operating path   enter ancillary supplies   increase lastmile transport
Measures:   climate solutions   ancillary supplies   new research   tough test   reset briefing   qualityassurance challenges   new report   local administration   key finding   damage effects   simple data   sport goods   adverse events   most people   drug substance   good restoration   additional supplies   priceless resources   upskil centers   cdc vaccine   datum locations   herd immunity   spin-dry ice   full collection   lastmile transport   2nd dose   covidcid1019 vaccines   past year   mckinsey analysis   dilute processes   emergent threat   emergent logistics   threat logistics   vend machine   query immunization   natural world   local redistribution   patient onboarding   next months   advance source   central storage   annual meeting   digital system   public education   risk areas   carbon storage   true transformation   natural climate   postpandemic organization   public adoption   first installments   requirement transport   administer record   invisible threat   digitize operations   import management   critical areas   critical months   final site   last week   common path   exaggerate rumor   track system   emergent storage   manufacture recertification   inventory management   identification system   logistic transport   curate collection   schedule dose   digital channels   natural resources   serious threats   clear path   local warehouse   usual meeting   operate path   climate challenge   material vaccine   new strains   slow start   biomedical source   administer events   industrial brands   regulatory use   manufacture substance   basic system   cold assignment   authorization approval   manufacture vaccine   schedule onboarding   visual insights   pointofcare storage   great note   urgent need   adverse event   new future   critical supplies   raw materials   human resources
Actions:   rebuild challenge   get aid   prioritization literature   delay production   prioritization system   manufacture fill   map path   update series   administer access   avoid emissions   include solutions   bolster system   vulnerability research   need onboarding   mitigate effects   slow destruction   increase transport   increase storage   relate suite   deliver vaccines   need vaccine   need it   represent threats   forecast management   need logistics   manage risk   consider need   coldchain logistics   continue map   reserve covid19   achieve immunity   highlight opportunities   delay challenges   choose images   visualize impact   challenge provider   reimagining organization   see collection   track locations   put these   scale areas   synchronize immunization   collaborate first   enter supplies   examine progress
This section lists the details about pathway-specific attributes.
Organization: